Latest Epinephrine autoinjector Stories
BASKING RIDGE, N.J., Aug. 14, 2012 /PRNewswire/ -- Mylan Specialty L.P., the fully-integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: MYL), today announced the EpiPen4Schools(TM) program. This effort offers four free EpiPen(®) or EpiPen Jr(® )(epinephrine) Auto-Injectors upon qualification, which includes having a valid prescription, to public and private kindergarten, elementary, middle and high schools in the U.S. The products will be available in the form of...
PARIS, Aug. 13, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Auvi-Q (epinephrine injection, USP) for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. Auvi-Q is the first-and-only compact epinephrine auto-injector with audio and visual cues that guide patients and caregivers step-by-step through the injection...
BASKING RIDGE, N.J. and NEW YORK, Aug. 7, 2012 /PRNewswire/ -- Mylan Specialty L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), and Pfizer Inc. (NYSE: PFE) today announced a license agreement, under which Pfizer will obtain the exclusive rights to market and sell EpiPen® Injection 0.3/0.15mg in Japan. These products, known in the U.S. as EpiPen® (epinephrine) 0.3mg and EpiPen Jr® (epinephrine) 0.15mg Auto-Injectors, are for self-administration for the emergency treatment of...
Is more epinephrine needed? A new study, conducted by the NIH-funded Consortium of Food Allergy Research and published in the June 25, 2012 issue of the journal Pediatrics, found that young children have an undetermined large number of reactions to milk and egg allergies and other foods. During a 3 year period, upwards of 70 percent of preschool children experience a higher reaction. Researchers also found that caregivers failed to administer the medication epinephrine in 70 percent...
Pfizer Canada Inc. and WestJet offer suggestions for a safer and less stressful travel experience KIRKLAND, QC and CALGARY, AB, May 15, 2012 /CNW/ - Pfizer Canada Inc., makers of EpiPen(®) (epinephrine) Auto-Injector, and WestJet today announced results of a survey commissioned to determine the concerns of Canadians at risk of anaphylaxis who may be travelling this summer. A total of 666 Canadian adults, who were all prescreened as being at risk of anaphylaxis,(a) or as...
PITTSBURGH and NEW YORK, Feb. 16, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue(TM), which will be manufactured and marketed by Sanofi-Aventis. According to...
Cholesterol-lowering medications may help millions fight heart disease, but this class of drugs may worsen asthma control, according to a study presented at the American College of Allergy, Asthma and Immunology Annual Meeting in Boston, Nov. 3-8. In the preliminary study researchers compared 20 patients with asthma taking prescribed cholesterol-lowering medication or statins, to 20 patients with asthma who did not take the drugs. The researchers found the patients taking statins had more...
Carrying an epinephrine auto-injector is a big responsibility - especially for a kid. Olli Lolli introduces a new line of allergy apparel for kids with life-threatening anaphylaxis. Perfect for back-to-school, Olli Lolli windbreakers and hoodies are specially designed with a built-in pocket to hold a child’s emergency auto-injector, ensuring the allergy medication is there when they need it. Toronto, ON (PRWEB) August 26, 2011 Having to remember an epinephrine auto-injector (e.g....
BASKING RIDGE, N.J., Aug. 24, 2011 /PRNewswire/ -- Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), today announced that Dey will exclusively offer the EpiPen 2-Pak® and EpiPen Jr 2-Pak® (epinephrine) Auto-Injector 0.3/0.15 mg, to encourage physicians and patients to follow recommendations by the National Institute of Allergy and Infectious Diseases (NIAID). While there is no safety issue with the EpiPen® and EpiPen Jr single package, Dey will transition away from...
BASKING RIDGE, N.J., May 10, 2011 /PRNewswire/ -- Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), is pleased to recognize the 14th annual Food Allergy Awareness Week (FAAW), May 8-14. Created by the Food Allergy and Anaphylaxis Network (FAAN) in 1997, FAAW aims to educate others and raise awareness about food allergies, a medical condition which affects one in 25 Americans.(1,2) Food allergies are the most common trigger of anaphylaxis,(3) a severe allergic reaction that can be...
